Synlogic
$4.099876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.18 (-4.22%) Today
$0.00 (0.00%) As of 12:34 PM UTC after-hours
Why Robinhood?
You can buy or sell Synlogic and other stocks, options, and ETFs commission-free!
About SYBX
Synlogic, Inc. Common Stock, also called Synlogic, is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA. The listed name for SYBX is Synlogic, Inc. Common Stock.
CEO
Aoife M. Brennan
Employees
76
Headquarters
Cambridge, Massachusetts
Founded
2017
Market Cap
128.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.68M
High Today
$4.25
Low Today
$3.95
Open Price
$4.14
Volume
520.36K
52 Week High
$4.30
52 Week Low
$1.35
Collections
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
SYBX Earnings
-$0.49
-$0.33
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market